Doliver Capital Advisors »

SPDR S&P Biotech shares owned by Doliver Capital Advisors

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Doliver Capital Advisors from 13F filings

Historical chart of Doliver Capital Advisors investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Doliver Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Doliver Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $224k 2.4k 94.89
2023-12-31 $215k 2.4k 89.29
2023-06-30 $211k 2.5k 83.20
2023-03-31 $207k 2.7k 76.21
2022-12-31 $259k 3.1k 83.00
2022-09-30 $249k 3.1k 79.30
2022-06-30 $277k 3.7k 74.32
2022-03-31 $296k 3.3k 89.97